About Bioline  All Journals  Testimonials  Membership  News  Donations

Australasian Biotechnology (backfiles)
ISSN: 1036-7128
Vol. 8, No. 2, 1998
Bioline Code: au98016
Full paper language: English
Document type: Research Article
Document available free of charge

Australasian Biotechnology (backfiles), Vol. 8, No. 2, 1998

 en Vaccine Biotechnology - Bacterial Vectors: why have they failed to deliver


Australasian Biotechnology,
Volume 8 Number 2, March/April 1998, pp. 86-90

Special Feature

Vaccine Biotechnology

Code Number:AU98016
Sizes of Files:
Text: 22K
Graphics: Photograph (jpg) - 59K

Our Special Feature for this issue highlights developments in Vaccine Biotechnology.

Bacterial Vectors: why have they failed to deliver ?

Richard Strugnell, Cameron Simmons, Odilia Wijburg, Tania Uren, Damien Drew and Sarah Dunstan,

Bacterial vaccine vectors have been studied experimentally for over twenty years yet there are no vector-based vaccines in commercial human or veterinary use today. The absence of human vector-based vaccines is probably due to problems associated with testing human vaccines, and a lack of funds to support vaccines for use in developing countries. Vector-based veterinary vaccines are currently not competitive with combination adjuvanted vaccines but may have a niche under certain circumstances. The future of vaccine vectors may lie in the delivery of DNA vaccines.

Copyright 1998 Australian Biotechnology Association Ltd.


Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 28-Nov-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil